SITAMET SR 1GM

261.00290.00 (-10%)

In stock

  • For use as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.
  • Also for use in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin or a PPARγ agonist (e.g., thiazolidinediones) when the single agent alone, with diet and exercise, does not provide adequate glycemic control.
Category:

Sitagliptin is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. This enzyme-inhibiting drug is to be used either alone or in combination with metformin or a thiazolidinedione for control of type 2 diabetes mellitus. The drug works to competitively inhibit a protein/enzyme, dipeptidyl peptidase 4 (DPP-4), that results in an increased amount of active incretins (GLP-1 and GIP), reduced amount of release of glucagon (diminishes its release) and increased release of insulin.

Only logged in customers who have purchased this product may leave a review.

Reviews

There are no reviews yet.

Main Menu

Placeholder

SITAMET SR 1GM

261.00290.00 (-10%)

Add to Cart